SCHEMBL37625

SCHEMBL37625

O=CC1CCC(=O)N1

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3194607 1.00
SCHEMBL845596 1.00
SCHEMBL5991463 0.86
SCHEMBL13438779 0.86
SCHEMBL3071586 0.84 CRBN (0.34)
SCHEMBL20445551 0.82 KMT2A (0.34)
SCHEMBL20444035 0.82 KMT2A (0.34)
SCHEMBL7428323 0.82 KMT2A (0.34)
SCHEMBL7433757 0.82 KMT2A (0.34)
SCHEMBL14928 0.78

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 873 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-1170827-C Benzofurylpyrone derivatives ������������ʽ���� 2004-10-13 CN claimed
EP-1063235-B1 BENZOFURYLPYRONE DERIVATIVES TEIJIN LTD (JP) 2004-05-12 EP claimed
US-20030186976-A1 Benzofurylpyrone derivatives TEIJIN LIMITED, MICROBIAL CHEMISTRY RESEARCH FOUNDATION 2003-10-02 US claimed
CN-1299359-A Benzofurylpyrone derivatives TEIJIN LTD (JP) 2001-06-13 CN claimed
EP-1063235-A1 BENZOFURYLPYRONE DERIVATIVES TEIJIN LIMITED (JP) 2000-12-27 EP claimed
EP-0406119-B1 New peptide derivatives, process of their preparation and pharmaceutical compositions containing them ADIR (FR) 1994-01-19 EP claimed
EP-0233155-A1 Aminoacyloxymethyl compounds CIBA-GEIGY AG (CH) 1987-08-19 EP claimed
EP-0201459-A1 Acylaminomethyl-penem compounds, their preparation and pharmaceutical formulations containing them CIBA-GEIGY AG (CH) 1986-11-12 EP claimed
JP-59144756-A None JP disclosed
WO-2025235957-A1 P53 MUTANT STABILIZER AND USES THEREOF FRONTIER MEDICINES CORPORATION (US) 2025-11-13 WO disclosed
US-12042541-B2 Lipids and compositions for the delivery of therapeutics ARBUTUS BIOPHARMA CORPORATION (CA) 2024-07-23 US disclosed
CN-118307422-A Biodegradable lipids for delivery of active agents 阿尔尼拉姆医药品有限公司 2024-07-09 CN disclosed
EP-3757090-B1 NOVEL LIPIDS AND COMPOSITIONS FOR THE DELIVERY OF THERAPEUTICS ARBUTUS BIOPHARMA CORP (CA) 2024-06-12 EP disclosed
CN-115279743-B Ionizable lipids for nucleic acid delivery 精密纳米系统无限责任公司 2024-05-14 CN disclosed
EP-0027260-A2 Peptides, processes for their preparation and pharmaceutical compositions containing them FUJISAWA PHARMACEUTICAL CO., LTD. (JP) 1981-04-22 EP disclosed
EP-0025842-A2 Peptides, process for their preparation, their pharmaceutical compositions and their intermediates FUJISAWA PHARMACEUTICAL CO., LTD. (JP) 1981-04-01 EP disclosed
US-4177346-A 1,5-Disubstituted-2-pyrrolidones PFIZER INC. (US) 1979-12-04 US disclosed
US-4113873-A 8-AZAPROSTANOIC ACID DERIVATIVES TANABE SEIYAKU CO. LTD. (JP) 1978-09-12 US disclosed
US-3867441-A NITRO-SUBSTITUTED PHENYLTHIO DOPAMINES HOFFMANN LA ROCHE 1975-02-18 US disclosed
US-3860630-A PHENETHYLAMIDE DERIVATIVES HOFFMANN LA ROCHE 1975-01-14 US disclosed